• Join
  • Login
  • Contact

Search abstracts

In vitro release study of timolol from novel hpmc/ha composite film for glaucoma treatment

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: TIGHSAZZADEH, Mo (University of Greenwich, Chemical, Pharmaceutical & Environmental Sciences)
  • Co-author(s): Mo Tighsazzadeh
    Joshua Boateng
  • Abstract:


    For ocular drug delivery, topical eye drops are the most commonly used dosage form; however, only 5% of the applied dose is absorbed into the eye. Therefore, a more effective drug delivery system is required for severe chronic eye conditions such as glaucoma to provide appropriate bioavailability.


    Optimised 1.5% (w/v) HPMC and 1%


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses